ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 107 filers reported holding ENDOLOGIX INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $104,000 | -57.2% | 145,667 | +14.6% | 0.00% | – |
| Q3 2018 | $243,000 | -66.2% | 127,112 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $719,000 | +33.6% | 127,112 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $538,000 | -22.5% | 127,112 | -1.9% | 0.00% | 0.0% |
| Q4 2017 | $694,000 | +16.8% | 129,635 | -2.7% | 0.00% | 0.0% |
| Q3 2017 | $594,000 | -16.1% | 133,282 | -8.5% | 0.00% | -50.0% |
| Q2 2017 | $708,000 | -38.8% | 145,685 | -8.8% | 0.00% | 0.0% |
| Q1 2017 | $1,156,000 | +20.9% | 159,685 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $956,000 | -56.5% | 167,185 | -2.6% | 0.00% | -60.0% |
| Q3 2016 | $2,196,000 | +3.7% | 171,585 | +0.9% | 0.01% | 0.0% |
| Q2 2016 | $2,118,000 | +62.9% | 169,985 | +9.3% | 0.01% | +66.7% |
| Q1 2016 | $1,300,000 | +5.1% | 155,526 | +24.4% | 0.00% | 0.0% |
| Q4 2015 | $1,237,000 | -17.8% | 124,973 | +1.8% | 0.00% | -25.0% |
| Q3 2015 | $1,505,000 | -20.3% | 122,730 | -0.3% | 0.00% | -20.0% |
| Q2 2015 | $1,889,000 | -5.5% | 123,130 | +5.2% | 0.01% | 0.0% |
| Q1 2015 | $1,998,000 | +10.1% | 117,076 | -1.3% | 0.01% | +25.0% |
| Q4 2014 | $1,815,000 | +44.9% | 118,676 | +0.4% | 0.00% | +33.3% |
| Q3 2014 | $1,253,000 | -29.5% | 118,171 | +1.1% | 0.00% | -25.0% |
| Q2 2014 | $1,778,000 | +21.1% | 116,900 | +2.5% | 0.00% | 0.0% |
| Q1 2014 | $1,468,000 | -26.0% | 114,100 | +0.4% | 0.00% | -20.0% |
| Q4 2013 | $1,983,000 | +8.9% | 113,700 | +0.7% | 0.01% | 0.0% |
| Q3 2013 | $1,821,000 | +25.3% | 112,900 | +3.2% | 0.01% | 0.0% |
| Q2 2013 | $1,453,000 | -6.4% | 109,432 | +13.8% | 0.01% | 0.0% |
| Q1 2013 | $1,553,000 | – | 96,187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|